Form 3 Filing by David Salton, Director of Intercure Ltd.

This filing details share options granted to David Salton, a director at Intercure Ltd. (INCR). Two grants are reported: the first on January 9, 2020, with an exercise price of $8.22 per share, fully vested by January 9, 2023. The second grant was on September 5, 2024, with an exercise price of $3.10 per share, vesting quarterly over four years. Both option grants are for Ordinary Shares, with 4,046 shares under the first grant and 15,000 shares under the second grant. The filing is signed by David Salton on April 16, 2026.